Hepatitis C infection: epidemiology, pathogenesis, and treatment

丙型肝炎感染：流行病学、发病机制和治疗

• 批准号: nhmrc : 1053206
• 负责人: A/Pr Michael Beard
• 金额: $ 379.74万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Program Grants
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/hepatitis-c-infection-pathogenesis-treatment/112320
• 关键词: Hepatitis; infection; epidemiology; pathogenesis; treatment

Hepatitis C affects a quarter of a million Australians, causing insidious but progressive liver disease which culminates in liver failure or cancer. There is no vaccine and prevention programs have limited effectiveness, but new antiviral therapies now offer high rates of cure. This Program will evaluate strategies to improve the health of those affected and prevent new infections by better understanding of the virus and the body’s immune response, including scarring and liver cancer formation.

丙型肝炎影响了25万澳大利亚人，导致阴险但进行性的肝脏疾病，最终导致肝功能衰竭或癌症。没有疫苗，预防计划的有效性有限，但新的抗病毒疗法现在提供了高治愈率。该方案将评估改善受影响者健康的战略，并通过更好地了解病毒和身体的免疫反应，包括疤痕和肝癌形成，预防新的感染。